查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1872099

左心室辅助装置（LVAD）－全球市占率和排名、总收入和需求预测（2025-2031年）

Left Ventricular Assist Device (LVAD) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
出版日期: | 出版商: QYResearch | 英文 102 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

全球左心室辅助装置（LVAD）市场预计在 2024 年达到 18.45 亿美元，预计到 2031 年将达到 34.95 亿美元，2025 年至 2031 年的复合年增长率为 9.2%。

本报告全面评估了左心室辅助装置（LVAD）的跨境产业布局、资本配置模式、区域经济相互依存关係，以及近期针对供应链重组的关税调整和国际战略应对措施。

左心室辅助装置（LVAD）是一种透过外科手术植入的机械循环支援装置，可以帮助左心室将血液泵送到全身。它主要用于等待心臟移植的晚期心臟衰竭患者（移植过渡治疗）、仿单标示外移植的患者（根治性治疗）或需要临时支持以促进心臟功能恢復的患者（恢復过渡治疗）。 LVAD由帮浦、驱动线、外部控制器和电源组成，可显着提高重度心臟衰竭患者的生存率和生活品质。

左心室辅助装置（LVAD）市场的主要驱动力是进行性心臟衰竭盛行率的不断上升以及等待心臟移植或不符合移植条件的患者人数的增加。 LVAD技术的进步，例如小型化泵、连续流系统和更长的电池寿命，显着提高了装置性能，降低了併发症率，并改善了患者的生存率和生活品质。此外，临床医师和病患对LVAD的认识不断提高，以及已开发国家有利的医保报销政策，正促使LVAD作为长期治疗方案得到更广泛的应用。

儘管左心室辅助装置（LVAD）具有许多临床优势，但其市场仍面临许多挑战。其中包括高昂的植入和维护成本，这限制了中低收入国家的普及。感染疾病、血栓症、出血和装置故障等严重併发症的风险仍然是患者和医疗服务提供者都非常关注的问题。此外，终身装置管理、对外部电源的依赖以及复杂的术后护理都会影响患者的依从性和治疗效果。监管障碍和专业手术中心数量有限也阻碍了LVAD的广泛应用。

本报告旨在对全球左心室辅助装置（LVAD）市场进行全面分析，重点关注总销售量、收入、价格、企业市场占有率和主要企业的排名，并按地区/国家、类型和应用对左心室辅助装置（LVAD）进行分析。

本报告以销售量（单位）和收入（百万美元）为单位，提供左心室辅助装置（LVAD）市场规模、估计值和预测，基准年为2024年，并包含2020年至2031年的历史数据和预测数据。定量和定性分析将帮助读者制定左心室辅助装置（LVAD）的业务和成长策略，评估市场竞争，分析自身在当前市场中的地位，并做出明智的商业决策。

市场区隔

公司

  • AbioMed
  • Abbott（Thoratec）
  • Medtronic（HeartWare）
  • Berlin Heart
  • Jarvik Heart
  • Sun Medical Technology Research
  • ReliantHeart
  • CH Biomedical

按类型分類的细分市场

  • BTT疗法
  • 目的地疗法（DT）
  • 其他的

应用领域

  • 医院
  • 诊所

按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 韩国
    • 东南亚
    • 印度
    • 澳洲
    • 亚太其他地区
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 荷兰
    • 北欧国家
    • 其他欧洲
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲
  • 中东和非洲
    • 土耳其
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他中东和非洲地区

The global market for Left Ventricular Assist Device (LVAD) was estimated to be worth US$ 1845 million in 2024 and is forecast to a readjusted size of US$ 3495 million by 2031 with a CAGR of 9.2% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Left Ventricular Assist Device (LVAD) cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

A Left Ventricular Assist Device (LVAD) is a mechanical circulatory support device that is surgically implanted to help the left ventricle pump blood to the rest of the body. It is primarily used in patients with advanced heart failure who are awaiting heart transplantation (bridge-to-transplant), not eligible for transplant (destination therapy), or need temporary support for heart recovery (bridge-to-recovery). The LVAD consists of a pump, a driveline, and an external controller and power source, and can significantly improve survival and quality of life in patients with severe cardiac dysfunction.

The Left Ventricular Assist Device (LVAD) market is primarily driven by the increasing prevalence of advanced heart failure and the growing number of patients who are either awaiting heart transplantation or are ineligible for transplant. Advances in LVAD technology-such as miniaturized pumps, continuous-flow systems, and improved battery life-have significantly enhanced device performance, reduced complication rates, and improved patient survival and quality of life. Additionally, expanding awareness among clinicians and patients, as well as favorable reimbursement policies in developed countries, are contributing to broader adoption of LVADs as a viable long-term treatment option.

Despite its clinical benefits, the LVAD market faces several challenges, including high costs of implantation and maintenance, which limit access in low- and middle-income countries. The risk of serious complications-such as infection, thrombosis, bleeding, and device malfunction-remains a significant concern for both patients and providers. Moreover, the need for lifelong device management, dependence on external power sources, and the complexity of post-operative care can affect patient adherence and outcomes. Regulatory hurdles and limited availability of specialized surgical centers also pose barriers to wider adoption.

This report aims to provide a comprehensive presentation of the global market for Left Ventricular Assist Device (LVAD), focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Left Ventricular Assist Device (LVAD) by region & country, by Type, and by Application.

The Left Ventricular Assist Device (LVAD) market size, estimations, and forecasts are provided in terms of sales volume (Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Left Ventricular Assist Device (LVAD).

Market Segmentation

By Company

  • AbioMed
  • Abbott (Thoratec)
  • Medtronic (HeartWare)
  • Berlin Heart
  • Jarvik Heart
  • Sun Medical Technology Research
  • ReliantHeart
  • CH Biomedical

Segment by Type

  • BTT Therapy
  • Destination Therapy (DT)
  • Other

Segment by Application

  • Hospitals
  • Clinics

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Left Ventricular Assist Device (LVAD) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Left Ventricular Assist Device (LVAD) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Left Ventricular Assist Device (LVAD) in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Left Ventricular Assist Device (LVAD) Product Introduction
  • 1.2 Global Left Ventricular Assist Device (LVAD) Market Size Forecast
    • 1.2.1 Global Left Ventricular Assist Device (LVAD) Sales Value (2020-2031)
    • 1.2.2 Global Left Ventricular Assist Device (LVAD) Sales Volume (2020-2031)
    • 1.2.3 Global Left Ventricular Assist Device (LVAD) Sales Price (2020-2031)
  • 1.3 Left Ventricular Assist Device (LVAD) Market Trends & Drivers
    • 1.3.1 Left Ventricular Assist Device (LVAD) Industry Trends
    • 1.3.2 Left Ventricular Assist Device (LVAD) Market Drivers & Opportunity
    • 1.3.3 Left Ventricular Assist Device (LVAD) Market Challenges
    • 1.3.4 Left Ventricular Assist Device (LVAD) Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Left Ventricular Assist Device (LVAD) Players Revenue Ranking (2024)
  • 2.2 Global Left Ventricular Assist Device (LVAD) Revenue by Company (2020-2025)
  • 2.3 Global Left Ventricular Assist Device (LVAD) Players Sales Volume Ranking (2024)
  • 2.4 Global Left Ventricular Assist Device (LVAD) Sales Volume by Company Players (2020-2025)
  • 2.5 Global Left Ventricular Assist Device (LVAD) Average Price by Company (2020-2025)
  • 2.6 Key Manufacturers Left Ventricular Assist Device (LVAD) Manufacturing Base and Headquarters
  • 2.7 Key Manufacturers Left Ventricular Assist Device (LVAD) Product Offered
  • 2.8 Key Manufacturers Time to Begin Mass Production of Left Ventricular Assist Device (LVAD)
  • 2.9 Left Ventricular Assist Device (LVAD) Market Competitive Analysis
    • 2.9.1 Left Ventricular Assist Device (LVAD) Market Concentration Rate (2020-2025)
    • 2.9.2 Global 5 and 10 Largest Manufacturers by Left Ventricular Assist Device (LVAD) Revenue in 2024
    • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Left Ventricular Assist Device (LVAD) as of 2024)
  • 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 BTT Therapy
    • 3.1.2 Destination Therapy (DT)
    • 3.1.3 Other
  • 3.2 Global Left Ventricular Assist Device (LVAD) Sales Value by Type
    • 3.2.1 Global Left Ventricular Assist Device (LVAD) Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Left Ventricular Assist Device (LVAD) Sales Value, by Type (2020-2031)
    • 3.2.3 Global Left Ventricular Assist Device (LVAD) Sales Value, by Type (%) (2020-2031)
  • 3.3 Global Left Ventricular Assist Device (LVAD) Sales Volume by Type
    • 3.3.1 Global Left Ventricular Assist Device (LVAD) Sales Volume by Type (2020 VS 2024 VS 2031)
    • 3.3.2 Global Left Ventricular Assist Device (LVAD) Sales Volume, by Type (2020-2031)
    • 3.3.3 Global Left Ventricular Assist Device (LVAD) Sales Volume, by Type (%) (2020-2031)
  • 3.4 Global Left Ventricular Assist Device (LVAD) Average Price by Type (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Hospitals
    • 4.1.2 Clinics
  • 4.2 Global Left Ventricular Assist Device (LVAD) Sales Value by Application
    • 4.2.1 Global Left Ventricular Assist Device (LVAD) Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Left Ventricular Assist Device (LVAD) Sales Value, by Application (2020-2031)
    • 4.2.3 Global Left Ventricular Assist Device (LVAD) Sales Value, by Application (%) (2020-2031)
  • 4.3 Global Left Ventricular Assist Device (LVAD) Sales Volume by Application
    • 4.3.1 Global Left Ventricular Assist Device (LVAD) Sales Volume by Application (2020 VS 2024 VS 2031)
    • 4.3.2 Global Left Ventricular Assist Device (LVAD) Sales Volume, by Application (2020-2031)
    • 4.3.3 Global Left Ventricular Assist Device (LVAD) Sales Volume, by Application (%) (2020-2031)
  • 4.4 Global Left Ventricular Assist Device (LVAD) Average Price by Application (2020-2031)

5 Segmentation by Region

  • 5.1 Global Left Ventricular Assist Device (LVAD) Sales Value by Region
    • 5.1.1 Global Left Ventricular Assist Device (LVAD) Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Left Ventricular Assist Device (LVAD) Sales Value by Region (2020-2025)
    • 5.1.3 Global Left Ventricular Assist Device (LVAD) Sales Value by Region (2026-2031)
    • 5.1.4 Global Left Ventricular Assist Device (LVAD) Sales Value by Region (%), (2020-2031)
  • 5.2 Global Left Ventricular Assist Device (LVAD) Sales Volume by Region
    • 5.2.1 Global Left Ventricular Assist Device (LVAD) Sales Volume by Region: 2020 VS 2024 VS 2031
    • 5.2.2 Global Left Ventricular Assist Device (LVAD) Sales Volume by Region (2020-2025)
    • 5.2.3 Global Left Ventricular Assist Device (LVAD) Sales Volume by Region (2026-2031)
    • 5.2.4 Global Left Ventricular Assist Device (LVAD) Sales Volume by Region (%), (2020-2031)
  • 5.3 Global Left Ventricular Assist Device (LVAD) Average Price by Region (2020-2031)
  • 5.4 North America
    • 5.4.1 North America Left Ventricular Assist Device (LVAD) Sales Value, 2020-2031
    • 5.4.2 North America Left Ventricular Assist Device (LVAD) Sales Value by Country (%), 2024 VS 2031
  • 5.5 Europe
    • 5.5.1 Europe Left Ventricular Assist Device (LVAD) Sales Value, 2020-2031
    • 5.5.2 Europe Left Ventricular Assist Device (LVAD) Sales Value by Country (%), 2024 VS 2031
  • 5.6 Asia Pacific
    • 5.6.1 Asia Pacific Left Ventricular Assist Device (LVAD) Sales Value, 2020-2031
    • 5.6.2 Asia Pacific Left Ventricular Assist Device (LVAD) Sales Value by Region (%), 2024 VS 2031
  • 5.7 South America
    • 5.7.1 South America Left Ventricular Assist Device (LVAD) Sales Value, 2020-2031
    • 5.7.2 South America Left Ventricular Assist Device (LVAD) Sales Value by Country (%), 2024 VS 2031
  • 5.8 Middle East & Africa
    • 5.8.1 Middle East & Africa Left Ventricular Assist Device (LVAD) Sales Value, 2020-2031
    • 5.8.2 Middle East & Africa Left Ventricular Assist Device (LVAD) Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Left Ventricular Assist Device (LVAD) Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Left Ventricular Assist Device (LVAD) Sales Value and Sales Volume
    • 6.2.1 Key Countries/Regions Left Ventricular Assist Device (LVAD) Sales Value, 2020-2031
    • 6.2.2 Key Countries/Regions Left Ventricular Assist Device (LVAD) Sales Volume, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Left Ventricular Assist Device (LVAD) Sales Value, 2020-2031
    • 6.3.2 United States Left Ventricular Assist Device (LVAD) Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Left Ventricular Assist Device (LVAD) Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Left Ventricular Assist Device (LVAD) Sales Value, 2020-2031
    • 6.4.2 Europe Left Ventricular Assist Device (LVAD) Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Left Ventricular Assist Device (LVAD) Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Left Ventricular Assist Device (LVAD) Sales Value, 2020-2031
    • 6.5.2 China Left Ventricular Assist Device (LVAD) Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Left Ventricular Assist Device (LVAD) Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Left Ventricular Assist Device (LVAD) Sales Value, 2020-2031
    • 6.6.2 Japan Left Ventricular Assist Device (LVAD) Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Left Ventricular Assist Device (LVAD) Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Left Ventricular Assist Device (LVAD) Sales Value, 2020-2031
    • 6.7.2 South Korea Left Ventricular Assist Device (LVAD) Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Left Ventricular Assist Device (LVAD) Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Left Ventricular Assist Device (LVAD) Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Left Ventricular Assist Device (LVAD) Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Left Ventricular Assist Device (LVAD) Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Left Ventricular Assist Device (LVAD) Sales Value, 2020-2031
    • 6.9.2 India Left Ventricular Assist Device (LVAD) Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Left Ventricular Assist Device (LVAD) Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 AbioMed
    • 7.1.1 AbioMed Company Information
    • 7.1.2 AbioMed Introduction and Business Overview
    • 7.1.3 AbioMed Left Ventricular Assist Device (LVAD) Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.1.4 AbioMed Left Ventricular Assist Device (LVAD) Product Offerings
    • 7.1.5 AbioMed Recent Development
  • 7.2 Abbott (Thoratec)
    • 7.2.1 Abbott (Thoratec) Company Information
    • 7.2.2 Abbott (Thoratec) Introduction and Business Overview
    • 7.2.3 Abbott (Thoratec) Left Ventricular Assist Device (LVAD) Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.2.4 Abbott (Thoratec) Left Ventricular Assist Device (LVAD) Product Offerings
    • 7.2.5 Abbott (Thoratec) Recent Development
  • 7.3 Medtronic (HeartWare)
    • 7.3.1 Medtronic (HeartWare) Company Information
    • 7.3.2 Medtronic (HeartWare) Introduction and Business Overview
    • 7.3.3 Medtronic (HeartWare) Left Ventricular Assist Device (LVAD) Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.3.4 Medtronic (HeartWare) Left Ventricular Assist Device (LVAD) Product Offerings
    • 7.3.5 Medtronic (HeartWare) Recent Development
  • 7.4 Berlin Heart
    • 7.4.1 Berlin Heart Company Information
    • 7.4.2 Berlin Heart Introduction and Business Overview
    • 7.4.3 Berlin Heart Left Ventricular Assist Device (LVAD) Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.4.4 Berlin Heart Left Ventricular Assist Device (LVAD) Product Offerings
    • 7.4.5 Berlin Heart Recent Development
  • 7.5 Jarvik Heart
    • 7.5.1 Jarvik Heart Company Information
    • 7.5.2 Jarvik Heart Introduction and Business Overview
    • 7.5.3 Jarvik Heart Left Ventricular Assist Device (LVAD) Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.5.4 Jarvik Heart Left Ventricular Assist Device (LVAD) Product Offerings
    • 7.5.5 Jarvik Heart Recent Development
  • 7.6 Sun Medical Technology Research
    • 7.6.1 Sun Medical Technology Research Company Information
    • 7.6.2 Sun Medical Technology Research Introduction and Business Overview
    • 7.6.3 Sun Medical Technology Research Left Ventricular Assist Device (LVAD) Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.6.4 Sun Medical Technology Research Left Ventricular Assist Device (LVAD) Product Offerings
    • 7.6.5 Sun Medical Technology Research Recent Development
  • 7.7 ReliantHeart
    • 7.7.1 ReliantHeart Company Information
    • 7.7.2 ReliantHeart Introduction and Business Overview
    • 7.7.3 ReliantHeart Left Ventricular Assist Device (LVAD) Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.7.4 ReliantHeart Left Ventricular Assist Device (LVAD) Product Offerings
    • 7.7.5 ReliantHeart Recent Development
  • 7.8 CH Biomedical
    • 7.8.1 CH Biomedical Company Information
    • 7.8.2 CH Biomedical Introduction and Business Overview
    • 7.8.3 CH Biomedical Left Ventricular Assist Device (LVAD) Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.8.4 CH Biomedical Left Ventricular Assist Device (LVAD) Product Offerings
    • 7.8.5 CH Biomedical Recent Development

8 Industry Chain Analysis

  • 8.1 Left Ventricular Assist Device (LVAD) Industrial Chain
  • 8.2 Left Ventricular Assist Device (LVAD) Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Left Ventricular Assist Device (LVAD) Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Left Ventricular Assist Device (LVAD) Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Left Ventricular Assist Device (LVAD) Market Trends
  • Table 2. Left Ventricular Assist Device (LVAD) Market Drivers & Opportunity
  • Table 3. Left Ventricular Assist Device (LVAD) Market Challenges
  • Table 4. Left Ventricular Assist Device (LVAD) Market Restraints
  • Table 5. Global Left Ventricular Assist Device (LVAD) Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global Left Ventricular Assist Device (LVAD) Revenue Market Share by Company (2020-2025)
  • Table 7. Global Left Ventricular Assist Device (LVAD) Sales Volume by Company (2020-2025) & (Units)
  • Table 8. Global Left Ventricular Assist Device (LVAD) Sales Volume Market Share by Company (2020-2025)
  • Table 9. Global Market Left Ventricular Assist Device (LVAD) Price by Company (2020-2025) & (US$/Unit)
  • Table 10. Key Manufacturers Left Ventricular Assist Device (LVAD) Manufacturing Base and Headquarters
  • Table 11. Key Manufacturers Left Ventricular Assist Device (LVAD) Product Type
  • Table 12. Key Manufacturers Time to Begin Mass Production of Left Ventricular Assist Device (LVAD)
  • Table 13. Global Left Ventricular Assist Device (LVAD) Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Left Ventricular Assist Device (LVAD) as of 2024)
  • Table 15. Mergers & Acquisitions, Expansion Plans
  • Table 16. Global Left Ventricular Assist Device (LVAD) Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 17. Global Left Ventricular Assist Device (LVAD) Sales Value by Type (2020-2025) & (US$ Million)
  • Table 18. Global Left Ventricular Assist Device (LVAD) Sales Value by Type (2026-2031) & (US$ Million)
  • Table 19. Global Left Ventricular Assist Device (LVAD) Sales Market Share in Value by Type (2020-2025)
  • Table 20. Global Left Ventricular Assist Device (LVAD) Sales Market Share in Value by Type (2026-2031)
  • Table 21. Global Left Ventricular Assist Device (LVAD) Sales Volume by Type: 2020 VS 2024 VS 2031 (Units)
  • Table 22. Global Left Ventricular Assist Device (LVAD) Sales Volume by Type (2020-2025) & (Units)
  • Table 23. Global Left Ventricular Assist Device (LVAD) Sales Volume by Type (2026-2031) & (Units)
  • Table 24. Global Left Ventricular Assist Device (LVAD) Sales Market Share in Volume by Type (2020-2025)
  • Table 25. Global Left Ventricular Assist Device (LVAD) Sales Market Share in Volume by Type (2026-2031)
  • Table 26. Global Left Ventricular Assist Device (LVAD) Price by Type (2020-2025) & (US$/Unit)
  • Table 27. Global Left Ventricular Assist Device (LVAD) Price by Type (2026-2031) & (US$/Unit)
  • Table 28. Global Left Ventricular Assist Device (LVAD) Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 29. Global Left Ventricular Assist Device (LVAD) Sales Value by Application (2020-2025) & (US$ Million)
  • Table 30. Global Left Ventricular Assist Device (LVAD) Sales Value by Application (2026-2031) & (US$ Million)
  • Table 31. Global Left Ventricular Assist Device (LVAD) Sales Market Share in Value by Application (2020-2025)
  • Table 32. Global Left Ventricular Assist Device (LVAD) Sales Market Share in Value by Application (2026-2031)
  • Table 33. Global Left Ventricular Assist Device (LVAD) Sales Volume by Application: 2020 VS 2024 VS 2031 (Units)
  • Table 34. Global Left Ventricular Assist Device (LVAD) Sales Volume by Application (2020-2025) & (Units)
  • Table 35. Global Left Ventricular Assist Device (LVAD) Sales Volume by Application (2026-2031) & (Units)
  • Table 36. Global Left Ventricular Assist Device (LVAD) Sales Market Share in Volume by Application (2020-2025)
  • Table 37. Global Left Ventricular Assist Device (LVAD) Sales Market Share in Volume by Application (2026-2031)
  • Table 38. Global Left Ventricular Assist Device (LVAD) Price by Application (2020-2025) & (US$/Unit)
  • Table 39. Global Left Ventricular Assist Device (LVAD) Price by Application (2026-2031) & (US$/Unit)
  • Table 40. Global Left Ventricular Assist Device (LVAD) Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 41. Global Left Ventricular Assist Device (LVAD) Sales Value by Region (2020-2025) & (US$ Million)
  • Table 42. Global Left Ventricular Assist Device (LVAD) Sales Value by Region (2026-2031) & (US$ Million)
  • Table 43. Global Left Ventricular Assist Device (LVAD) Sales Value by Region (2020-2025) & (%)
  • Table 44. Global Left Ventricular Assist Device (LVAD) Sales Value by Region (2026-2031) & (%)
  • Table 45. Global Left Ventricular Assist Device (LVAD) Sales Volume by Region (Units): 2020 VS 2024 VS 2031
  • Table 46. Global Left Ventricular Assist Device (LVAD) Sales Volume by Region (2020-2025) & (Units)
  • Table 47. Global Left Ventricular Assist Device (LVAD) Sales Volume by Region (2026-2031) & (Units)
  • Table 48. Global Left Ventricular Assist Device (LVAD) Sales Volume by Region (2020-2025) & (%)
  • Table 49. Global Left Ventricular Assist Device (LVAD) Sales Volume by Region (2026-2031) & (%)
  • Table 50. Global Left Ventricular Assist Device (LVAD) Average Price by Region (2020-2025) & (US$/Unit)
  • Table 51. Global Left Ventricular Assist Device (LVAD) Average Price by Region (2026-2031) & (US$/Unit)
  • Table 52. Key Countries/Regions Left Ventricular Assist Device (LVAD) Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 53. Key Countries/Regions Left Ventricular Assist Device (LVAD) Sales Value, (2020-2025) & (US$ Million)
  • Table 54. Key Countries/Regions Left Ventricular Assist Device (LVAD) Sales Value, (2026-2031) & (US$ Million)
  • Table 55. Key Countries/Regions Left Ventricular Assist Device (LVAD) Sales Volume, (2020-2025) & (Units)
  • Table 56. Key Countries/Regions Left Ventricular Assist Device (LVAD) Sales Volume, (2026-2031) & (Units)
  • Table 57. AbioMed Company Information
  • Table 58. AbioMed Introduction and Business Overview
  • Table 59. AbioMed Left Ventricular Assist Device (LVAD) Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 60. AbioMed Left Ventricular Assist Device (LVAD) Product Offerings
  • Table 61. AbioMed Recent Development
  • Table 62. Abbott (Thoratec) Company Information
  • Table 63. Abbott (Thoratec) Introduction and Business Overview
  • Table 64. Abbott (Thoratec) Left Ventricular Assist Device (LVAD) Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 65. Abbott (Thoratec) Left Ventricular Assist Device (LVAD) Product Offerings
  • Table 66. Abbott (Thoratec) Recent Development
  • Table 67. Medtronic (HeartWare) Company Information
  • Table 68. Medtronic (HeartWare) Introduction and Business Overview
  • Table 69. Medtronic (HeartWare) Left Ventricular Assist Device (LVAD) Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 70. Medtronic (HeartWare) Left Ventricular Assist Device (LVAD) Product Offerings
  • Table 71. Medtronic (HeartWare) Recent Development
  • Table 72. Berlin Heart Company Information
  • Table 73. Berlin Heart Introduction and Business Overview
  • Table 74. Berlin Heart Left Ventricular Assist Device (LVAD) Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 75. Berlin Heart Left Ventricular Assist Device (LVAD) Product Offerings
  • Table 76. Berlin Heart Recent Development
  • Table 77. Jarvik Heart Company Information
  • Table 78. Jarvik Heart Introduction and Business Overview
  • Table 79. Jarvik Heart Left Ventricular Assist Device (LVAD) Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 80. Jarvik Heart Left Ventricular Assist Device (LVAD) Product Offerings
  • Table 81. Jarvik Heart Recent Development
  • Table 82. Sun Medical Technology Research Company Information
  • Table 83. Sun Medical Technology Research Introduction and Business Overview
  • Table 84. Sun Medical Technology Research Left Ventricular Assist Device (LVAD) Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 85. Sun Medical Technology Research Left Ventricular Assist Device (LVAD) Product Offerings
  • Table 86. Sun Medical Technology Research Recent Development
  • Table 87. ReliantHeart Company Information
  • Table 88. ReliantHeart Introduction and Business Overview
  • Table 89. ReliantHeart Left Ventricular Assist Device (LVAD) Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 90. ReliantHeart Left Ventricular Assist Device (LVAD) Product Offerings
  • Table 91. ReliantHeart Recent Development
  • Table 92. CH Biomedical Company Information
  • Table 93. CH Biomedical Introduction and Business Overview
  • Table 94. CH Biomedical Left Ventricular Assist Device (LVAD) Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 95. CH Biomedical Left Ventricular Assist Device (LVAD) Product Offerings
  • Table 96. CH Biomedical Recent Development
  • Table 97. Key Raw Materials Lists
  • Table 98. Raw Materials Key Suppliers Lists
  • Table 99. Left Ventricular Assist Device (LVAD) Downstream Customers
  • Table 100. Left Ventricular Assist Device (LVAD) Distributors List
  • Table 101. Research Programs/Design for This Report
  • Table 102. Key Data Information from Secondary Sources
  • Table 103. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Left Ventricular Assist Device (LVAD) Product Picture
  • Figure 2. Global Left Ventricular Assist Device (LVAD) Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Left Ventricular Assist Device (LVAD) Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Global Left Ventricular Assist Device (LVAD) Sales Volume (2020-2031) & (Units)
  • Figure 5. Global Left Ventricular Assist Device (LVAD) Sales Price (2020-2031) & (US$/Unit)
  • Figure 6. Left Ventricular Assist Device (LVAD) Report Years Considered
  • Figure 7. Global Left Ventricular Assist Device (LVAD) Players Revenue Ranking (2024) & (US$ Million)
  • Figure 8. Global Left Ventricular Assist Device (LVAD) Players Sales Volume Ranking (2024) & (Units)
  • Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Left Ventricular Assist Device (LVAD) Revenue in 2024
  • Figure 10. Left Ventricular Assist Device (LVAD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 11. BTT Therapy Picture
  • Figure 12. Destination Therapy (DT) Picture
  • Figure 13. Other Picture
  • Figure 14. Global Left Ventricular Assist Device (LVAD) Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 15. Global Left Ventricular Assist Device (LVAD) Sales Value Market Share by Type, 2024 & 2031
  • Figure 16. Global Left Ventricular Assist Device (LVAD) Sales Volume by Type (2020 VS 2024 VS 2031) & (Units)
  • Figure 17. Global Left Ventricular Assist Device (LVAD) Sales Volume Market Share by Type, 2024 & 2031
  • Figure 18. Global Left Ventricular Assist Device (LVAD) Price by Type (2020-2031) & (US$/Unit)
  • Figure 19. Product Picture of Hospitals
  • Figure 20. Product Picture of Clinics
  • Figure 21. Global Left Ventricular Assist Device (LVAD) Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 22. Global Left Ventricular Assist Device (LVAD) Sales Value Market Share by Application, 2024 & 2031
  • Figure 23. Global Left Ventricular Assist Device (LVAD) Sales Volume by Application (2020 VS 2024 VS 2031) & (Units)
  • Figure 24. Global Left Ventricular Assist Device (LVAD) Sales Volume Market Share by Application, 2024 & 2031
  • Figure 25. Global Left Ventricular Assist Device (LVAD) Price by Application (2020-2031) & (US$/Unit)
  • Figure 26. North America Left Ventricular Assist Device (LVAD) Sales Value (2020-2031) & (US$ Million)
  • Figure 27. North America Left Ventricular Assist Device (LVAD) Sales Value by Country (%), 2024 VS 2031
  • Figure 28. Europe Left Ventricular Assist Device (LVAD) Sales Value, (2020-2031) & (US$ Million)
  • Figure 29. Europe Left Ventricular Assist Device (LVAD) Sales Value by Country (%), 2024 VS 2031
  • Figure 30. Asia Pacific Left Ventricular Assist Device (LVAD) Sales Value, (2020-2031) & (US$ Million)
  • Figure 31. Asia Pacific Left Ventricular Assist Device (LVAD) Sales Value by Region (%), 2024 VS 2031
  • Figure 32. South America Left Ventricular Assist Device (LVAD) Sales Value, (2020-2031) & (US$ Million)
  • Figure 33. South America Left Ventricular Assist Device (LVAD) Sales Value by Country (%), 2024 VS 2031
  • Figure 34. Middle East & Africa Left Ventricular Assist Device (LVAD) Sales Value, (2020-2031) & (US$ Million)
  • Figure 35. Middle East & Africa Left Ventricular Assist Device (LVAD) Sales Value by Country (%), 2024 VS 2031
  • Figure 36. Key Countries/Regions Left Ventricular Assist Device (LVAD) Sales Value (%), (2020-2031)
  • Figure 37. Key Countries/Regions Left Ventricular Assist Device (LVAD) Sales Volume (%), (2020-2031)
  • Figure 38. United States Left Ventricular Assist Device (LVAD) Sales Value, (2020-2031) & (US$ Million)
  • Figure 39. United States Left Ventricular Assist Device (LVAD) Sales Value by Type (%), 2024 VS 2031
  • Figure 40. United States Left Ventricular Assist Device (LVAD) Sales Value by Application (%), 2024 VS 2031
  • Figure 41. Europe Left Ventricular Assist Device (LVAD) Sales Value, (2020-2031) & (US$ Million)
  • Figure 42. Europe Left Ventricular Assist Device (LVAD) Sales Value by Type (%), 2024 VS 2031
  • Figure 43. Europe Left Ventricular Assist Device (LVAD) Sales Value by Application (%), 2024 VS 2031
  • Figure 44. China Left Ventricular Assist Device (LVAD) Sales Value, (2020-2031) & (US$ Million)
  • Figure 45. China Left Ventricular Assist Device (LVAD) Sales Value by Type (%), 2024 VS 2031
  • Figure 46. China Left Ventricular Assist Device (LVAD) Sales Value by Application (%), 2024 VS 2031
  • Figure 47. Japan Left Ventricular Assist Device (LVAD) Sales Value, (2020-2031) & (US$ Million)
  • Figure 48. Japan Left Ventricular Assist Device (LVAD) Sales Value by Type (%), 2024 VS 2031
  • Figure 49. Japan Left Ventricular Assist Device (LVAD) Sales Value by Application (%), 2024 VS 2031
  • Figure 50. South Korea Left Ventricular Assist Device (LVAD) Sales Value, (2020-2031) & (US$ Million)
  • Figure 51. South Korea Left Ventricular Assist Device (LVAD) Sales Value by Type (%), 2024 VS 2031
  • Figure 52. South Korea Left Ventricular Assist Device (LVAD) Sales Value by Application (%), 2024 VS 2031
  • Figure 53. Southeast Asia Left Ventricular Assist Device (LVAD) Sales Value, (2020-2031) & (US$ Million)
  • Figure 54. Southeast Asia Left Ventricular Assist Device (LVAD) Sales Value by Type (%), 2024 VS 2031
  • Figure 55. Southeast Asia Left Ventricular Assist Device (LVAD) Sales Value by Application (%), 2024 VS 2031
  • Figure 56. India Left Ventricular Assist Device (LVAD) Sales Value, (2020-2031) & (US$ Million)
  • Figure 57. India Left Ventricular Assist Device (LVAD) Sales Value by Type (%), 2024 VS 2031
  • Figure 58. India Left Ventricular Assist Device (LVAD) Sales Value by Application (%), 2024 VS 2031
  • Figure 59. Left Ventricular Assist Device (LVAD) Industrial Chain
  • Figure 60. Left Ventricular Assist Device (LVAD) Manufacturing Cost Structure
  • Figure 61. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 62. Bottom-up and Top-down Approaches for This Report
  • Figure 63. Data Triangulation
  • Figure 64. Key Executives Interviewed